JUN 30, 2020 9:47 PM PDT

UK Loosens Regulation on Prescription CBD for Epilepsy

WRITTEN BY: Angela Dowden

Epidyolex—the epilepsy drug that contains the non-psychoactive cannabis chemical cannabidiol, or CBD—has been changed from a controlled drug to one that's available over the counter by the UK’s Home Office, signalling a big uptick in official confidence in the medicinal cannabis category.

It comes two months after a similar de-scheduling in the USA—in April 2020 the Drug Enforcement Agency announced that Epidiolex (the American and European spellings are different) was also no longer a controlled substance. US physicians can now prescribe the medicine free of the requirements of state prescription drug monitoring programs.

The UK regulatory relaxation of the drug is a particularly big deal given Epidyolex was only accelerated into the UK’s National Health Service late last year (recreational cannabis is illegal in the UK). The medication is licensed for the treatment of severe intractable forms of epilepsy such as Lennox Gastaut syndrome and Dravet syndrome.

On appearing in Britain’s national formulary Epidyolex was a schedule 2 controlled drug, putting it in the same category as methadone and diamorphine (drugs that not only require a doctor’s prescription but also have strict record keeping and storage requirements). The announced change—to schedule 5—is game-changing as schedule 5 is the least strict category, for medications that don’t even require a prescription and can be bought over the counter in pharmacies.

The move appears symbolic—a tacit nod to CBD being safe. There are many CBD products on the UK being marketed as food supplements, but there has been an uneasy relationship with regulators who still clamp down heavily on any products found to contain more than a tiny percentage of the main psychoactive in cannabis, THC.

CEO of UK cannabinoid supplier Grow Pharma, Pierre van Weperen, believes the move to make Epydiolex schedule 5 is a move in the right direction but that the country’s regulators need to ease up on the THC ban for further progress. “The two most important regulations for the UK to be changed are the very strict limitations on importing THC or THC-containing products, which create issues around availability and cost for patients that could easily be resolved,” he told labiotech.eu. “The other issue is in terms of allowing the UK to export CBD- and THC-containing products. The UK could very well become a leader in European medicinal cannabis if these regulations were relaxed.”

Sources: Labiotech.eu, GW Pharmaceuticals, High Times

About the Author
  • I'm a Journalist and author with many year's experience of writing for both a consumer and professional audience, mostly on nutrition, health and medical prescribing. My background is food science and I'm a registered nutritionist.
You May Also Like
SEP 24, 2020
Health & Medicine
Pregnancy Cannabis Use Linked With Psychotic Behaviors in Offspring
SEP 24, 2020
Pregnancy Cannabis Use Linked With Psychotic Behaviors in Offspring
Women are already warned that using marijuana during pregnancy might affect their baby’s growth in the womb, but a ...
OCT 06, 2020
Clinical & Molecular DX
A Smart Tattoo That Could Save Your Life
OCT 06, 2020
A Smart Tattoo That Could Save Your Life
Color-changing tattoos, powered by nanotechnology, that sense imbalances in your biochemistry providing a visual signal ...
OCT 05, 2020
Health & Medicine
Cannabis Chemotherapy Trial Shows Encouraging Phase II Results
OCT 05, 2020
Cannabis Chemotherapy Trial Shows Encouraging Phase II Results
Even with the best anti-nausea medications one in three patients receiving chemotherapy experiences vomiting, and about ...
OCT 09, 2020
Cannabis Sciences
Older Adults Use Cannabis for Common Health Problems
OCT 09, 2020
Older Adults Use Cannabis for Common Health Problems
Researchers from the University of California San Diego have found that older adults tend to use cannabis for medical pu ...
OCT 21, 2020
Immunology
CNS's immune cells - Microglia are involved in the exacerbation of MS
OCT 21, 2020
CNS's immune cells - Microglia are involved in the exacerbation of MS
Multiple sclerosis (MS) is one of the most progressive autoimmune diseases that affect the central nervous system where ...
OCT 19, 2020
Genetics & Genomics
Early Childhood Trauma Affects Metabolism in the Next Generation
OCT 19, 2020
Early Childhood Trauma Affects Metabolism in the Next Generation
Traumatic experiences can have a lasting impact, and kids that suffer through them can feel the effects for a lifetime. ...
Loading Comments...